Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion – Chemical & Engineering News
Chemical & Engineering News |
Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion
Chemical & Engineering News A cartoon illustrating the structure of AAV9, the virus AveXis uses to deliver its gene therapies into the brain and spinal cord. Novartis plans to acquire the neurological gene therapy firm AveXis for $8.7 billion. The purchase will bolster the Swiss … How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal Novartis to buy Avexis in $8.7 billion gene–therapy deal Novartis signs $8.7bn gene therapy deal |
